In the current study, plasma ICAM-1 and VCAM-1 levels were higher in DM patients compared to matched healthy controls, and among DM patients CAM levels were higher in anti-MDA5 ab + patients and in patients with ILD. Here, ICAM1 is linked to dermatomyositis.